Anti-IL-5 and anti-IL-5 receptor therapy significantly improves quality of life and FEV1 values in patients with severe asthma. - Alfaro, Anaiza Odalis Villalobos; Vargas, Haydee Carolina Gutiérrez; Díaz, Juan Manuel; Pinto, Jonathan Alvarez; Cambero, Diana Cristina García; Cuellar, Eduardo Hernandez; Zapata, Julio Augusto Palma; Domínguez, Alondra Esthefanía Llamas; Zapata, Juliana Palma; Ponce-Campos, Silvia Denise (Allergy, Asthma & Clinical Immunology, 2025)